The Michael J. Fox Foundation for Parkinson’s Research (MJFF) changed the name of its large, observational study of Parkinson’s disease patients from the Parkinson’s Progression Markers Initiative (PPMI) to the Parkinson’s Precision Medicine Initiative, reflecting a major shift in Parkinson’s disease research. The foundation said the name change…
News
A specialized prebiotic supplement can restore healthy gut bacteria in people with Parkinson’s disease, and researchers have discovered a way to track this progress through a simple blood test. By measuring tiny particles in the blood that carry signals between the gut and the brain, scientists can now observe…
A woman diagnosed with early-onset Parkinson’s disease — later found to be caused by a mutation in the VPS13C gene — initially responded well to medication and deep brain stimulation (DBS), but then experienced rapid worsening of both her motor and nonmotor symptoms, ultimately leaving her unable to live…
By analyzing data sets from both humans and fruit flies and conducting experiments in living fruit flies, researchers have identified several genes that may be risk factors or useful therapeutic targets in Parkinson’s disease, according to a study. “We were particularly excited to find that manipulation of STAM1/2, INPP4A/B,…
The 2026 Parkinson’s Unity Walk raised almost $2 million, with more than 3,000 people participating in the 1.2-mile walk in New York’s Central Park on April 25, The Michael J. Fox Foundation (MJFF) said. An anonymous donor helped, matching every dollar raised up to $1.4 million. The…
A small clinical trial testing whether a probiotic supplement could ease anxiety in people with Parkinson’s disease found that it was no better than a placebo. However, patients given the supplement showed significant improvements on cognitive tests compared with those given the placebo. The researchers cautioned that this finding…
Aligning Science Across Parkinson’s (ASAP) and The Michael J. Fox Foundation for Parkinson’s Research (MJFF) are together investing $261 million in new grant funding to better understand what drives Parkinson’s disease and to accelerate the development of more personalized therapies. The monies will expand the Collaborative…
Routine gut biopsies may turn up evidence of protein misfolding, predicting the risk of developing neurodegenerative diseases such as Parkinson’s disease years before neurological symptoms appear, a study suggested. Researchers from the University of Aberdeen, NHS Grampian, and NHS Highland found that more than half of people who had digestive…
In Parkinson’s disease, toxic clumps of alpha-synuclein protein not only damage brain cells but also weaken the lining of blood vessels, with both processes likely working together to drive disease progression, according to a study by researchers from Binghamton University in New York and Drexel University in Philadelphia. “Parkinson’s…
Women with Parkinson’s disease are far less likely than men to undergo deep brain stimulation (DBS), in part because they are less likely to have reliable support and more likely to worry about being a burden on their loved ones. That’s according to the study, “How Women…
Recent Posts
- Combined cognitive, biomarker testing targets Parkinson’s, related disorders
- 5 ways to make your home more Parkinson’s friendly and safe
- Brain chemical changes may be tied to Parkinson’s cognitive issues
- Pivotal trial of adaptive deep brain stimulation device hits key milestone
- Parkinson’s changed my uncle’s role, but not what he brought to the table